Hjem › Type 2-diabetes › Alabama › Birmingham
Kliniske studier for Type 2-diabetes i Birmingham, AL
16 studier for Type 2-diabetes søker deltakere på steder i og rundt Birmingham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Rekrutterer
- University of Alabama, Birmingham
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Rekrutterer
- University of Alabama, Birmingham
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
RekruttererFase 3
- Cahaba Research, Inc. - Trussville Location, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RekruttererFase 3
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RekruttererFase 3
- AURORA-2 Clinical Site, Birmingham
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
RekruttererFase 2
- Central Research Associates - Flourish - PPDS, Birmingham
- AES - DRS - Synexus Clinical Research US, Inc. - Birmingham, Birmingham
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
RekruttererFase 2
- Flourish Research, Birmingham
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
Rekrutterer
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RekruttererFase 3
- Research Site, Birmingham
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RekruttererFase 3
- Univ of Alabama Birmingham, Birmingham
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
RekruttererFase 3
- Research Site, Birmingham
CGM for Management of Type 2 Diabetes in Pregnancy
Rekrutterer
- University of Alabama at Birmingham, Birmingham
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
RekruttererFase 2
- Central Research Associates, LLC dba Flourish Research, Birmingham
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
RekruttererObservasjonsstudie
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
Rekrutterer
- The Worship Center Cristian Church, Birmingham
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
Rekrutterer
- University of Alabama at Birmingham/ Children's of Alabama, Birmingham
Type 2-diabetes-studier i andre byer
- San Antonio, TX37 studier
- Houston, TX31 studier
- Orlando, FL24 studier
- Boston, MA20 studier
- Miami, FL19 studier
- Chicago, IL19 studier
- Dallas, TX19 studier
- Columbus, OH18 studier
- Las Vegas, NV18 studier
- Atlanta, GA17 studier
- San Diego, CA17 studier
- Los Angeles, CA16 studier
Andre studier i Birmingham
- Kreft (alle typer)30 studier
- Brystkreft24 studier
- Fedme23 studier
- Eggstokkreft23 studier
- Ikke-småcellet lungekreft22 studier
- Akut myelogen leukemi21 studier
- Multipelt myelom18 studier
- KOLS17 studier
- Kardiovaskulær sykdom17 studier
- Overvekt16 studier
- Endometriekreft16 studier
- Cystisk fibrose16 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.